WWHealthcare · Medical Care FacilitiesThe 4 Wall Street analysts covering WW International, Inc. hold a median 12-month price target of $28 — +126.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 69 of 100 as at 4 Nov 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores WW International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (98): The share count has been shrinking and the company is not leaning on new borrowing.
Growth (6): Sales and profits are flat, shrinking, or growing more slowly than they were.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on WW, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +126.7% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 Oct 2026 | Northland Capital Markets | Initiates | Outperform | $25 |
| 15 Jan 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 15 Jan 2026 | Morgan Stanley | Maintains | Equal-Weight | $38 → $35 |
| 12 Aug 2025 | Morgan Stanley | Maintains | Equal-Weight | — |
| 8 July 2025 | LUCID CAPITAL MARKETS | Initiates | Buy | — |
| 10 Oct 2024 | Barclays | Maintains | Underweight | $0.75 |
| 2 Aug 2024 | Barclays | Maintains | Underweight | — |
| 2 Aug 2024 | Guggenheim | Maintains | Buy | — |
| 2 Aug 2024 | UBS | Maintains | Neutral | — |
| 3 May 2024 | DA Davidson | Maintains | Buy | — |
| 25 Apr 2024 | UBS | Maintains | Neutral | — |
| 18 Mar 2024 | Guggenheim | Reiterates | Buy | — |
| 14 Mar 2024 | DA Davidson | Maintains | Buy | — |
| 4 Mar 2024 | DA Davidson | Reiterates | Buy | — |
| 1 Mar 2024 | Barclays | Maintains | Underweight | — |
| 29 Feb 2024 | UBS | Maintains | Neutral | — |
| 1 Feb 2024 | Goldman Sachs | Maintains | Buy | — |
| 23 Jan 2024 | Goldman Sachs | Maintains | Buy | — |
| 20 Dec 2023 | Guggenheim | Initiates | Buy | — |
| 9 Oct 2023 | DA Davidson | Reiterates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
WW appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, WW International, Inc. returned −60.9% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 73% of US stocks
Cheaper than 91% of US stocks
Cheaper than 83% of US stocks
Cheaper than 53% of US stocks
Higher than 14% of US stocks
Higher than 2% of US stocks
Higher than 83% of US stocks
Higher than 61% of US stocks
Higher than 17% of US stocks
Higher than 27% of US stocks
Higher than 42% of US stocks
Higher than 93% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
WW International, Inc. has a market value of $133.9M and an enterprise value of $458.7M.
Revenue in the twelve months to 30 June 2026: $677.7M. The latest quarter shrank 14.2% year on year.
Net income over the same four quarters: −$100.0M, a −14.8% net margin.
Free cash flow in the twelve months to 30 June 2026: −$26.8M, after $23.1M of capital spending.
Trailing P/E: 0.1×; forward P/E: −581.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 5.09%, paying out 0% of earnings.
WW International, Inc. employs 3,500 people — $194K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own WW International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research says WW International has what it describes as the two key ingredients for a likely earnings beat in its upcoming report, and highlights expectations ahead of next week’s release.
Why it matters — The item previews WW’s upcoming earnings report and the expectations investors may be watching.
Zacks Investment Research says recent movements in the options market warrant close attention to WW International stock. The excerpt does not specify what those movements indicate.
Why it matters — WW watchers may note options-market activity as a signal to monitor, though the excerpt gives no details about its direction or implications.
WW International said it will release its third-quarter 2026 results before market open on Thursday, November 5, 2026. The quarter ended September 30, 2026.
Why it matters — WW watchers can note the scheduled date for the company’s quarterly results and related conference call.
Weight Watchers (WW International) announced a new collaboration with Google Health Enterprise that combines wearable technology and AI-powered health insights with Weight Watchers' clinically proven weight health program. The partnership is intended to enhance engagement and outcomes in weight health programs.
Why it matters — This collaboration signals a strategic move to integrate advanced technology into WW's offerings, which could strengthen its weight-management program and appeal to health-conscious consumers.
WW International executives outlined efforts to reposition the company's weight-management business around behavioral support, telehealth, and GLP-1 medications, following a restructuring that substantially reduced its debt burden. The company is focused on a cash flow turnaround as its GLP-1 care initiatives gain momentum.
Why it matters — WW watchers would care because the company's shift toward GLP-1-focused care and its reduced debt load signal a strategic repositioning aimed at improving its financial trajectory.
The 4 Wall Street analysts covering WW International, Inc. have a median 12-month price target of $28, with estimates ranging from $20 to $35. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 4 analysts covering WW International, Inc., 2 rate it a Buy, 2 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks WW International, Inc. 69 out of 100 across roughly 4,600 US stocks as at 4 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 4 Nov 2026, WW International, Inc. ranks 69 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (98 of 100).
No one can know that. What the data says: the median 12-month target from 4 analysts implies +126.7% from the last close, and Ticker Nerd's factor model ranks WW International, Inc. 69 out of 100 as at 4 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering WW International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for WW are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $20 to $35 over the next 12 months.
WW International, Inc. returned -60.9% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
WW International is a global wellness company offering science-backed weight management programs and services. Founded in 1963 and headquartered in New York, the company operates under the Weight Watchers brand, providing a comprehensive ecosystem designed to support sustainable weight loss and healthy lifestyle changes.
The most recent item we track (Zacks Investment Research, 29 Oct 2026): "WW International, Inc. (WW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release". Zacks Investment Research says WW International has what it describes as the two key ingredients for a likely earnings beat in its upcoming report, and highlights expectations ahead of next week’s release.
WW International is a global wellness company offering science-backed weight management programs and services. Founded in 1963 and headquartered in New York, the company operates under the Weight Watchers brand, providing a comprehensive ecosystem designed to support sustainable weight loss and healthy lifestyle changes. WW delivers its programs through multiple channels: digital platforms featuring mobile apps and online tools, in-person wellness workshops led by certified coaches, and virtual coaching services. The company's flagship myWW+ program utilizes the SmartPoints system, which quantifies foods based on nutritional content including carbohydrates, fat, and fiber. WW also operates a clinical division offering GLP-1 medication programs for eligible members, integrating pharmaceutical interventions with behavioral support. Beyond core subscription services, WW generates revenue through licensed branded food products, cookbooks, and merchandise. The company serves members across North America and international markets, positioning itself as a comprehensive weight health platform that combines behavioral techniques, nutritional guidance, clinical care, technology-enabled support, and community connection to help members achieve lasting results.
CEO Ms. Tara M. Comonte · 3,500 employees · United States · https://corporate.ww.com
